The $1.1 million funding from National Science Foundation’s Small Business Innovation Research program will help develop technology for biopharmaceutical analysis.
The U.K.’s universal health care coverage and easy access to healthcare services, along with the growing elderly population and increasing rates of disease, have provided momentum for growth.
Pharmaceutical companies Pfizer, GlaxoSmithKline, AstraZeneca and Bristol-Myers Squibb will take part in the 20.4 million-euro ($29.2 million) project.
Inspection and maintenance procedures are important to avoiding problems caused by ineffective clamp connections, including product contamination, leakage, and costly downtime.
Because biotechnology companies produce complex molecules for human use, there is need to monitor and control all aspects of this complicated process to ensure safe, viable and consistent products.
The Atrato flowmeter leverages Titan's patented ultrasonic flowmeter technology enabling the direct-through meter to handle flows from laminar to turbulent.